Omega Therapeutics

[Available On-Demand]
Search General Info
Search Education
Search Partnering Companies
Omega Therapeutics is a preclinical stage genomics medicine enterprise that is transforming medicine and patient care through precision genomic control. We are interrogating the central dogma of biology and illuminating the role of genomic activation at the pre-transcriptional level as a new way to treat and potentially cure disease by precisely controlling genomic expression without changing nucleic acid sequences.
Omega has created a foundational proprietary knowledge base of Insulated Genomic Domains (IGDs) and their biological functions in both healthy and diseased states across cell types. IGDs function as the fundamental regulators, or GenomStats™, of the human genome.

This scientific insight drives our discovery and development of genomic modulators, or Omega Controllers™. We engineer them to precisely tune genomic activity to desired therapeutic levels through control of the GenomStats™. This allows us to treat disease without altering the human genetic code.
Ticker:
Not Provided
Exchange:
Not Provided
Company Type:
Not Provided
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
n/a
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President & CEO
Omega Therapeutics